The Bristol Myers Squibb Foundation Diversity in Clinical Trials Career Development Program Announces First Group of Physicians to be Trained
Retrieved on:
Wednesday, October 20, 2021
Clinical Trials, Philanthropy, Practice Management, Other Health, Biotechnology, Managed Care, Pharmaceutical, Health, Other Philanthropy, Oncology, the Bristol Myers Squibb Foundation, National Medical Fellowships, the American Association for Cancer Research, THE BRISTOL MYERS SQUIBB FOUNDATION, NATIONAL MEDICAL FELLOWSHIPS, THE AMERICAN ASSOCIATION FOR CANCER RESEARCH
The Bristol Myers Squibb Foundation (BMSF), together with its partners, National Medical Fellowships (NMF) and the American Association for Cancer Research (AACR), today announced the first group of 52 physicians selected for its Diversity in Clinical Trials Career Development Program (BMSF DCTCDP).
Key Points:
- The Bristol Myers Squibb Foundation (BMSF), together with its partners, National Medical Fellowships (NMF) and the American Association for Cancer Research (AACR), today announced the first group of 52 physicians selected for its Diversity in Clinical Trials Career Development Program (BMSF DCTCDP).
- The 52 early-stage investigators are the first of 250 community-oriented clinical trialists who will be trained through the program by 2027.
- Many aspects of the Bristol Myers Squibb Foundation Diversity in Clinical Trials Career Development Program make it unique, said Eliseo J. Prez-Stable, M.D., Director of the National Institute on Minority Health and Health Disparities, National Institutes of Health.
- For more information about Bristol Myers Squibb, visit us at BMS.com or follow us on LinkedIn , Twitter , YouTube , Facebook , and Instagram .